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Objective: To compare the uptake of maternal syphilis and HIV screening, intermittent preventive treatment for
malaria, and tetanus toxoid administration in three regions of Ghana, before and after the rollout of syphilis
point-of-care tests (POCTs).Methods: Antenatal register records were reviewed in 15 selected health facilities
over an eight-month period, 16 months apart. Register records had been evaluated using the maternal record
booklets as a gold standard in a separate prior survey. Results: In the evaluation study, the sensitivity of register
data was low, ranging from 33.3% for tetanus toxoid administration to 53.8% for syphilis serology. In total, 8282
antenatal client records (4141 in each period) were reviewed. Less than a third of pregnantwomen received any
single intervention at either period (ranging from 17.8% for tetanus toxoid to 29.8% for HIV testing). Overall, HIV
screening had a marginal absolute increase of about 2% while the remaining interventions experienced non-
signiﬁcant absolute decreases of 4.1 to11.1%. When adjusting for under-recording, syphilis screening uptake
was 50% before and 33.6% after the introduction of POCTs. Conclusion: Use of POCTs for syphilis did not result
in increased uptake. Routine monitoring of antenatal interventions using the antenatal register may result in
underestimation of their uptake.
© 2015WorldHealthOrganization; licensee Elsevier. This is an openaccess article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Background
Syphilis in pregnancy accounts for over half a million entirely pre-
ventable perinatal deaths annually [1]. Yet, only less than 40% of
women receiving antenatal care (ANC) in Sub-Saharan Africa are
screened for syphilis [2]. Control of congenital syphilis is a global prior-
ity; the World Health Organization initiative for the Global Elimination
of Congenital Syphilis stipulates that at least 90% of pregnant women
should be tested for syphilis and that no less than 90% of those found
to be seropositive should receive adequate treatment by 2015 [1]. To
achieve these targets, antenatal syphilis testing (AST) with rapid
point-of-care tests (POCTs) and same-day benzathine penicillin treat-
ment (usually at the ﬁrst antenatal visit) for seropositive women is
currently recommended [1,3,4].
Given the poor implementation of syphilis screening for pregnant
women and the reported dramatic increases in antenatal syphilisnd Gynecology, Komfo Anokye
+23 324 462 3287.
lsevier. This is an open access articleseroprevalence in Ghana [5–7], a national rollout of rapid syphilis
POCTs for pregnantwomenwas undertaken in 2009, offering an unprec-
edented opportunity to increase the uptake of screening and treatment.
However, estimating such an uptake, especially in low- and middle-
income countries such as Ghana, remains a major challenge [8]. While
routinely collected data, such as ANC register records, are valuable and
remain the only accessible resource, their completeness and accuracy
are often doubted [9,10]. Therefore, an assessment of the accuracy of
ANC register data was required to provide useful estimates of the uptake
of interventions delivered in the antenatal setting in Ghana.
The aims of the present study were to compare the uptake of AST
and treatment in three regions of Ghana, before and after the rollout
of syphilis POCTs, and to assess the accuracy of ANC registers regarding
documentation of AST results and treatment. Uptake of AST was also
compared with three other recommended antenatal interventions,
namely prevention ofmother-to-child transmission of HIV, intermittent
preventive treatment formalaria in pregnancy (IPTp), and prevention of
maternal and neonatal tetanus (tetanus toxoid), as tracer control inter-
ventions. We hypothesized that the rollout of syphilis POCTs in Ghana
would increase AST and treatment uptake; however, uptake of the
tracer control interventions was not expected to change over time.under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Sociodemographic characteristics of women attending antenatal clinics in selected
healthcare facilities in Ghana.a
Characteristic Number of women
(n = 390)
Age group, y
18–19 29 (7.4)
20–24 103 (26.4)
25–29 116 (29.7)
30–34 86 (22.1)
35–46 56 (14.4)
Mean (standard deviation) 27.4 (5.8)
Marital status
Single 15 (3.8)
Married/cohabiting 375 (96.2)
Education
No formal education 117 (30.0)
Basic education 210 (53.8)
Secondary or higher education 63 (16.2)
Occupation (woman)
Professional 24 (6.2)
Vocational 85 (21.8)
Trading/business 144 (36.9)
Manual/farmer 94 (24.1)
Unemployed 43 (11.0)
Occupation (spouse)
Professional 75 (19.2)
Vocational 128 (32.8)
Trading/business 60 (15.4)
Manual/farmer 124 (31.8)
Unemployed 3 (0.8)
Parity b
0 98 (25.8)
1–2 168 (44.2)
3–10 114 (30.0)
Median (Interquartile range) 2 (0–3)
Trimester at booking c
First trimester 178 (48.1)
Second trimester 180 (48.7)
Third trimester 12 (3.2)
a Values are given as number (percentage) unless otherwise indicated.
b Parity, 10 missing values.
c Trimester at booking, 20 missing values.
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2.1. Study context and settings
A revamping of routineASTwasperformed by theGhanaHealth Ser-
vice through the National AIDS/STI Control Programme in 2009 [11].
Contrary to previous practice, where ASTwas carried out by trained lab-
oratory personnel using non-treponemal tests, these POCTs were to be
used by trained midwives at the antenatal clinic in all facilities. Details
of the implementation, including training, supply chain management,
and testing and treatment guidelines are the subject of a related study
(unpublished data).
Based on reported treponemal seroprevalence from the 2004–2009
national HIV/syphilis sentinel surveys [6,7], we categorized the 10 ad-
ministrative regions of Ghana into three strata: regions with seropreva-
lence of greater than 10%, 5%− 10%, and less than 5%. One region was
selected from each category and according to one of three geographical
locations, namely southern,middle, andnorthern sectors of the country,
often used as “representative” regions in other Ghanaian health surveys
[12]; the Central, Ashanti, and Northern regions were thus selected.
Within each region, two districts were randomly selected, except in the
Central region, where one district, which had the highest seroprevalence
of treponemal infections in the country, was purposively selected.
In each region, the teaching, regional, and district hospitals (of
selected districts) were included. One smaller health unit with at least
20 antenatal registrants per month was also randomly selected from
each district to represent all levels of implementation of the ANC inter-
vention. The teaching and regional hospitals in the Ashanti region were
not included owing to a known lack of documentation of AST results in
the ANC register and the relatively low antenatal clinic attendance, re-
spectively. A total of 15 health facilitieswere selected: three district hos-
pitals, one private hospital, and one health center in the Ashanti region;
one regional hospital, two district hospitals, and two health centers in
the Central region; and one teaching hospital, two district hospitals,
and two health centers in the Northern region.
2.2. Estimating uptake of key antenatal interventions
Retrospective register record reviews covering four months in each
of two phaseswere conducted tomeasure uptake of AST before (January
to April 2009) and after (September to December 2010) the national
rollout of syphilis POCTs. A period of 16 months (May 2009 to August
2010)was chosen to allow enough time for the national rollout to elapse
before review and ensure the same duration of observation in both
periods. Register records were selected from each facility by systematic
random sampling using the ANC register as the sampling frame.
For purposes of conﬁdentiality, in some facilities, syphilis or HIV test
resultswere recorded in special books for the two interventionswithout
documentation in the ANC register. We searched for the test results of
selected clients from these special books up to three months post-
registration (as documented in the ANC register). If the test results for
a given client were not found in the books, we assumed the test was
not performed for this particular case. Three hospitals, one in each
region, also had similar IPTp and tetanus toxoid administration books
and recording practices during both periods. However, due to time con-
straints, we could not review these during our assessment.
2.3. Validation sub-study
There are two main sources of ANC data in Ghana: the maternal re-
cord booklet (MRB [or ANC card]) and the ANC register. The former is
the primary record of all clinical evaluations, including history, physical
examination, laboratory investigations, and interventions/treatments
given, while the latter is a summary of key assessments and interven-
tions [13], commonly extracted from the MRB before the attendee
leaves the clinic. The MRB is kept by the attendee, who presents it ateach ANC visit, while the ANC register is retained at the health facility.
Hence, ANC register recording of the four interventions was validated
against those in the MRB as the gold standard. IPTp was given after the
ﬁrst trimester, while the remaining three interventions were to be ad-
ministered at the ﬁrst ANC visit regardless of the trimester [13]. Results
of tests performed in the laboratory (e.g. syphilis testing)were recorded
in the MRB or ANC register at the subsequent visit. Therefore, antenatal
clinic attendees who had had at least one prior antenatal visit and in the
second trimester of their pregnancy in each of the 15 selected
healthcare facilities were systematically selected during the second
phase using the ANC register (records for the day) as the sampling
frame. The sampling fraction varied from one in two to one in four
attendees depending on the number of eligible women, with the ﬁrst
being randomly selected. Selected attendees were approached individ-
ually after their antenatal evaluations and invited to participate in the
study if found eligible according to their MRB. Consenting clients were
then interviewed using a structured questionnaire and documentation
of each of the four interventions in the MRB and ANC register was
reviewed and compared.
Sensitivity was deﬁned as the proportion of women whose test re-
sults or treatments were recorded in the ANC register among those
who had test results or treatments recorded in the MRB. Speciﬁcity
was the proportion ofwomenwhodid not have any test results or treat-
ments recorded in the ANC register among those who had no test re-
sults or treatments recorded in the MRB [10,14,15]. Positive predictive
value (PPV)was deﬁned as the proportion of womenwhose test results
or treatments were recorded in the MRB among those whose test re-
sults or treatments were recorded in the ANC register. Negative
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test results or treatments recorded in theMRB among thosewhodid not
have any test results or treatments recorded in the ANC register [10,14,
15]. The Kappa statistic was the agreement betweenMRB and ANC reg-
ister records beyond chance [10,14,15]; Kappa values greater than 0.75,
0.4− 0.75, and less than 0.4 indicate excellent, good, and poor agree-
ment, respectively [10,14,15].
2.4. Sample size calculations
For the register validation study, a sample size of 360 women (24
women per clinic) was required to estimate a measure of PPV or NPV
of 30% and 90% (95% conﬁdence intervals [CIs] 22%–39% and 83%–95%,
respectively). An average of 420 and 120 ANC register records in each
phase gave at least 80% power to detect minimum absolute differences
of 10% and 20% in AST uptake in the larger hospitals and smaller health
facilities, respectively, following the rollout.
2.5. Statistical analyses
All analyseswere performed using Stata version 11.0 software (Stata
Corp, College Station, TX, USA). Sensitivity, speciﬁcity, PPV, and NPV
with exact binomial 95% CIs to correctly identify testing status and
treatment byMRB as the gold standard were calculated. Agreement be-
tween the two recording methods (MRB and ANC register) was
assessed by the percentage overall agreement (p) = (a + d)/N,
where a is the number recorded by both methods, d is the number
not recorded by either method, and N is the total sample; the percent-
age negative agreement = d/[0.5*(N–a + d)]; the percentage positive
agreement = a/[0.5*(N + a–d)]; and the prevalence-adjusted bias-
adjusted Kappa = 2p–1 [16].Table 2
Comparing documentation of syphilis andHIV testing, intermittent preventive treatment forma
in the antenatal care register and maternal record booklet.
Intervention by region and
level of health facility
Result/treatment recorded in
MRB ANC
register
Both Neither Total
(n)
PA
(%)
NA
(%)
OA
(%)
Syphilis screening
Ashanti region 56 26 25 73 130 61.0 82.0 75.
Central region 87 66 59 36 130 77.1 67.3 73.
Northern region a 43 17 16 34 78 53.3 70.8 64.
Private Hosp./Health Centre 62 38 34 38 104 68.0 70.4 69.
Teaching/Reg./Dist. Hosp. 124 71 66 105 234 67.7 76.9 73.
Total (all facilities) 186 109 100 143 338 67.8 75.1 71.
HIV screening
Ashanti region 78 30 28 50 130 51.9 65.8 60.
Central region 98 49 44 27 130 59.9 47.8 54.
Northern region b 79 38 38 51 104 83.5 87.2 85.
Private Hosp./Health Centre 88 47 43 64 130 78.9 84.8 82.
Teaching/Reg./Dist. Hosp. 167 70 67 64 234 56.5 55.4 56.
Total (all facilities) 255 117 110 128 364 63.6 67.2 65.
IPTp
Ashanti region 73 22 18 53 130 37.9 64.2 54.
Central region 71 41 32 50 130 57.1 67.6 63.
Northern region 91 67 60 32 130 76.0 62.8 70.
Private Hosp./Health Centre 100 69 56 43 156 66.3 60.1 63.
Teaching/Reg./Dist. Hosp. 135 61 54 92 234 55.1 67.7 62.
Total (all facilities) 235 130 110 135 390 60.3 65.1 62.
Tetanus toxoid
Ashanti region 67 8 8 63 130 21.3 68.1 54.
Central region 70 24 21 57 130 44.7 68.7 60.
Northern region 88 50 46 38 130 66.7 62.3 64.
Private Hosp./Health Centre 95 50 43 54 156 59.3 64.7 62.
Teaching/Reg./Dist. Hosp. 130 32 32 104 234 39.5 68.0 58.
Total (all facilities) 225 82 75 158 390 48.9 66.8 59.
Abbreviations: ANC, antenatal care; CI, conﬁdence interval; Dist., District; Hosp., Hospital; IPTp, i
NA, negative agreement; NPV, negative predictive value; OA, overall agreement; PA, positive a
a Two health centres in the Northern region were not conducting syphilis testing at the tim
b One health center in the Northern region was not conducting HIV testing.To compare coverage of the four interventions before and after the
rollout of syphilis POCTs, differences in uptake with 95% CIs were calcu-
lated using the survey “svy” command in Stata to take account of clus-
tering and number of records reviewed in each facility.
The study was approved by the institutional review boards of the
Ghana Health Service and Kwame Nkrumah University of Science and
Technology, Ghana, and the London School of Hygiene and Tropical
Medicine, UK.3. Results
3.1. Validation sub-study
A total of 390 women (26 from each facility) were recruited for
the validation study. The sociodemographic characteristics of the
women are shown in Table 1. About a quarter of the women were
primigravidas and nearly all (97%) had had a ﬁrst antenatal visit
before the third trimester.
Generally, all four interventions appeared under-recorded in the
ANC register with low and variable sensitivities of 11.9% to 67.8% and
relatively higher speciﬁcities of 76.8% to 100% (Table 2). Overall, sensi-
tivity of AST recording was the highest compared with the other three
interventions (53.8% vs b50%). Except for one facility, all PPVs were
over 80% while NPVs were generally lower, ranging from 33.3% to
70.2%. Validation measures varied across regions. Except for sensitivity,
speciﬁcity, PPV, and NPV were generally higher for hospitals compared
with the smaller health facilities.
Overall, the Kappa scores for syphilis and HIV testing were poor to
good, and poor for IPTp and tetanus toxoid administration; Kappa
ratings varied across regions. Except for AST, scores were generallylaria in pregnancy, and tetanus toxoid administration, by region and type of health facility,
Kappa Sensitivity %
(95% CI)
Speciﬁcity %
(95% CI)
PPV % (95% CI) NPV % (95% CI)
4 0.51 44.6 (31.3, 58.5) 98.6 (92.7, 100) 96.2 (80.4, 99.9) 70.2 (60.4, 78.8)
1 0.46 67.8 (56.9, 77.4) 83.7 (69.3, 93.2) 89.4 (79.4, 95.6) 56.3 (43.3, 68.6)
1 0.28 37.2 (23.0, 53.3) 97.1 (85.1, 99.9) 94.1 (71.3, 99.9) 55.7 (42.4, 68.5)
2 0.38 54.8 (41.7, 67.5) 95.7 (89.5, 98.8) 89.5 (75.2, 97.1) 57.6 (44.8, 69.7)
1 0.46 53.2 (44.1, 62.2) 95.5 (89.7, 98.5) 93.0 (84.3, 97.7) 64.4 (56.6, 71.7)
9 0.44 53.8 (46.3, 61.1) 94.1 (89.1, 97.3) 91.7 (84.9, 96.2) 62.4 (55.8, 68.7)
0 0.20 35.9 (25.3, 47.6) 96.2 (86.8, 99.5) 93.3 (77.9, 99.2) 50.0 (39.8, 60.2)
6 0.09 44.9 (34.8, 55.3) 84.4 (67.2, 94.7) 89.8 (77.8, 96.6) 33.3 (23.2, 44.7)
6 0.71 48.1 (36.7, 59.6) 100 (86.3, 100) 100 (90.7, 100) 37.9 (26.2, 50.7)
3 0.65 48.9 (38.1, 59.8) 90.5 (77.4, 97.3) 91.5 (79.6, 97.6) 45.8 (34.8, 57.1)
0 0.12 40.1 (32.6, 48.0) 95.5 (87.5, 99.1) 95.7 (88.0, 99.1) 39.0 (31.5, 46.9)
4 0.31 43.1 (37.0, 49.5) 93.6 (87.2, 97.4) 94.0 (88.1, 97.6) 41.3 (35.1, 47.7)
6 0.09 24.7 (15.3, 36.1) 93.0 (83.0, 98.1) 81.8 (59.7, 94.8) 49.1 (39.3, 58.9)
1 0.26 45.1 (33.2, 57.3) 84.7 (73.0, 92.8) 78.0 (62.4, 89.4) 56.2 (45.3, 66.7)
8 0.42 65.9 (55.3, 75.5) 82.1 (66.5, 92.5) 89.6 (79.7, 95.7) 50.8 (37.9, 63.6)
5 0.27 56.0 (45.7, 65.9) 76.8 (63.6, 87.0) 81.2 (69.9, 89.6) 49.4 (38.5, 60.4)
4 0.25 40.0 (31.7, 48.8) 92.9 (86.0, 97.1) 88.5 (77.8, 95.3) 53.2 (45.5, 60.8)
8 0.26 46.8 (40.3, 53.4) 87.1 (80.8, 91.9) 84.6 (77.2, 90.3) 51.9 (45.7, 58.1)
6 0.09 11.9 (5.3, 22.2) 100 (94.3, 100) 100 (63.1, 100) 51.6 (42.4, 60.8)
0 0.20 30.0 (19.6, 42.1) 95.0 (86.1, 99.0) 87.5 (67.6, 97.3) 53.8 (43.8, 63.5)
6 0.29 52.3 (41.4, 63.0) 90.5 (77.4, 97.3) 92.0 (80.8, 97.8) 47.5 (36.2, 59.0)
2 0.24 45.3 (35.0, 55.8) 88.5 (77.8, 95.3) 86.0 (73.3, 94.2) 50.9 (41.0, 60.8)
1 0.16 26.4 (17.5, 32.9) 100 (96.5, 100) 100 (89.1, 100) 51.5 (44.4, 58.6)
7 0.19 33.3 (27.2, 39.9) 95.8 (91.5, 98.3) 91.5 (83.2, 96.5) 51.3 (45.6, 57.0)
ntermittent preventive treatment formalaria in pregnancy;MRB,maternal record booklet;
greement; PPV, positive predictive value; Reg., Regional.
e.
Table 3
Number of antenatal clinic registrants before (2009) and after (2010) the rollout of syphilis point-of-care testing policy screened for syphilis or HIV or given intermittent preventive treatment for malaria in pregnancy (IPTp) or tetanus toxoid ad-
ministration, by region and health facility level, among 4141 antenatal care (ANC) register records reviewed in 2009 and 4141 in 2010.a
Region and type
of health facility
Records
reviewed or
available b
Syphilis screening HIV screening IPTp Tetanus toxoid
No. (%) No. (%) No. (%) No. (%)
2009 2010 2009 2010 2009 2010 2009 2010
Ashanti region
Health Centre 1 120 0 (0) 83 (69.2) 26 (21.7) 92 (76.7) 20 (16.7) 50 (41.7) 4 (3.3) 0 (0)
Private Hospital 119 0 (0) 17 (14.3) 0 (0) 13 (10.9) 1 (0.8) 9 (7.6) 7 (5.9) 15 (12.6)
District Hospital 1 419 302 (72.1) 111 (26.5) 189 (45.1) 75 (17.9) 0 (0) 9 (2.2) 0 (0) 9 (2.2)
District Hospital 2 420 0 (0) 4 (1.0) 59 (14.1) 28 (6.7) NR NR NR NR
District Hospital 3 414 0 (0) 53 (12.8) 75 (18.1) 100 (24.2) 170 (41.1) 11 (2.7) 182 (44.0) 11 (2.7)
Subtotal 1492 302/1492 (20.2) 268/1492 (18.0) 349/1492 (23.4) 308/1492 (20.6) 191/1072 (17.8) 79/1072 (7.4) 193/1072 (18.0) 35/1072 (3.3)
Central region
Health Centre 2 119 30 (25.2) 28 (23.5) 1 (0.8) 42 (35.3) 47 (39.5) 36 (30.3) 51 (42.9) 46 (38.7)
Health Centre 3 120 1 (0.8) 6 (5.0) 0 (0) 25 (20.8) 1 (0.8) 8 (6.7) 0 (0) 9 (7.5)
District Hospital 4 265 173 (65.3) 55 (20.8) 155 (58.5) 189 (71.3) 71 (26.8) 98 (37.0) 27 (10.2) 18 (6.8)
District Hospital 5 420 343 (81.7) 1 (0.2) 300 (71.4) 243 (57.9) 34 (8.1) 0 (0) 93 (22.1) 0 (0)
Regional Hospital 236 200 (84.7) 148 (62.7) 154 (65.3) 0 (0) NR NR NR NR
Subtotal 1160 747/1160 (64.4) 238/1160 (20.5) 610/1160 (52.6) 499/1160 (43.0) 153/924 (16.6) 142/924 (15.4) 171/924 (18.5) 73/924 (7.9)
Northern region
Health Centre 4 119 NT NT 0 (0) 0 (0) 91 (76.5) 18 (15.1) 101 (84.9) 21 (17.7)
Health Centre 5 120 NT NT NT NT 59 (49.2) 37 (30.8) 82 (68.3) 75 (62.5)
District Hospital 6 420 0 (0) 0 (0) 35 (8.3) 163 (38.8) NR NR NR NR
District Hospital 7 416 0 (0) 184 (44.2) NR NR 282 (67.8) 372 (88.9) 290 (69.7) 322 (77.4)
Teaching Hospital 414 0 (0) 15 (3.6) 3 (0.72) 106 (25.6) 29 (7.0) 33 (8.0) 48 (11.6) 20 (4.8)
Subtotal 1498 0/1250 (0) 199/1250 (15.9) 38/953 (4.0) 269/953 (28.2) 461/1069 (43.1) 458/1069 (42.8) 521/1069 (48.7) 438/1069 (41.0)
Level of health facility
Private Hosp./Health Centre 717 31/478 (6.5) 134/478 (28.0) 27/597 (4.5) 172/597 (28.8) 219/717 (30.5) 158/717 (22.0) 245/717 (34.2) 166/717 (23.2)
Teaching/Reg./Dist. Hospital 3424 1018/3424 (29.7) 571/3424 (16.7) 970/3008 (30.0) 904/3008 (32.2) 586/2348 (25.0) 521/2348 (22.2) 640/2348 (27.3) 380/2348 (16.2)
Total (all facilities) 4141 1049/3902 (26.9) 705/3902 (18.1) 997/3605 (27.6) 1076/3605 (29.8) 805/3605 (26.3) 679/3605 (22.2) 885/3605 (28.9) 546/3605 (17.8)
Abbreviations: Dist., District; Hosp., Hospital; NR, intervention not recorded in antenatal clinic register; NT, syphilis/HIV tests not conducted in facility; Reg., Regional.
a Facilities that did not record the intervention (NR) or carry out HIV/syphilis tests (NT) were excluded from the analysis.
b Records reviewed/available each year (equal number of records were extracted in each facility for 2009 and 2010).
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compared with larger hospitals (Table 2).
3.2. Uptake of key antenatal interventions
A total of 8282 ANC client records were reviewed from 15 selected
facilities; speciﬁcally, 4141 records each in the pre- and post-POCT roll-
out phases. Altogether, nearly 90% of the women booked for ANC in the
ﬁrst two trimesters and the majority (91%) of women screened for
syphilis did so at this time. According to data from the ANC registers,
less than a third (17.8% to 29.8%) of women received all interventions
at each period, with HIV testing having the highest uptake.
All health facilities in the Central region and one district hospital in
the Ashanti regionwere already screening pregnant women for syphilis
in the pre-rollout phase in 2009. By 2010, 16 months after national roll-
out, all but two health centers in the Northern region were screening
pregnant women for syphilis (Table 3). In one district hospital in the
Northern region, pregnant women were not screened for syphilis
throughout the entire period of this evaluation, despite national policy.
However, paradoxically, overall, more pregnant women were offered
ASTs in 2009 compared with 2010 (26.9% vs 18.1%), representing a
statistically non-signiﬁcant absolute decrease of 8.8% (P= 0.47).
Almost all health facilities that were previously not screening preg-
nantwomen for syphilis had absolute increases in AST uptake, following
the rollout. In contrast, with the exception of one health center, all other
facilities that performed AST in 2009 had an absolute reduction in AST
uptake in 2010 (Tables 3 and 4). Generally, signiﬁcant absolute
decreases in AST (up to 81% in one district hospital) were observed in
the larger hospitals, while marginal absolute reductions or signiﬁcant
absolute increases (up to nearly +70% in one health center) were ob-
served in the smaller facilities. At the regional level, the Central region
had the highest absolute reduction in AST (43.9%; P= 0.07). Provision
of syphilis treatment to seropositive women could not be ascertained
because there were no columns in the ANC register to record it.
Adjusting for under-recording, as recommended [17], indicated an
AST uptake of 50.0% and 33.6% in 2009 and 2010, respectively, thusTable 4
Differences in proportion of antenatal clinic registrants screened for syphilis or HIV or given int
by region and level of health facility level, before (2009) and after (2010) rollout of point-of-ca
Region and type of
health facility
Syphilis screening HIV screening
% Diff. (95% CI) P value % Diff. (95% CI)
Ashanti region
Health Centre 1 69.2 (60.8− 77.5) b0.001 55.0 (44.3− 65.7)
Private Hospital 14.3 (7.9− 20.6) b0.001 10.9 (5.3− 16.6)
District Hospital 1 –45.6 (–51.6 to –39.5) b0.001 –27.2 (–33.2 to –21
District Hospital 2 1.0 (0.02− 1.9) 0.05 –7.4 (–11.5 to –3.3)
District Hospital 3 12.8 (9.6− 16.0) b0.001 6.0 (0.5− 11.6)
Subtotal –2.3 (–46.3 to 41.7) 0.89 –2.8 (–30.1 to 24.6)
Central region
Health Centre 2 –1.7 (–12.7− 9.3) 0.74 34.5 (25.6− 43.3)
Health Centre 3 4.2 (–0.1− 8.4) 0.06 20.8 (13.5− 28.2)
District Hospital 4 –44.5 (–52.1 to –37.0) b0.001 12.8 (4.7− 20.9)
District Hospital 5 –81.4 (–85.2 to –77.7) b0.001 –13.6 (–20.0 to –7.2
Regional Hospital –22.0 (–29.8 to –14.3) b0.001 –65.3 (–71.4 to –59
Subtotal –43.9 (–92.8 to 5.0) 0.07 –9.6 (–52.0 to 32.9)
Northern region
Health Centre 4 – – –
Health Centre 5 – – –
District Hospital 6 – – 30.5 (25.1− 35.8)
District Hospital 7 44.2 (39.4− 49.0) b0.001 –
Teaching Hospital 3.6 (1.8− 5.4) b0.001 24.9 (20.6− 29.2)
Subtotal 15.9 (–45.1 to 76.9) 0.38 24.2 (2.6− 45.8)
Level of health facility
Private Hosp./Health Centre 21.5 (–30.2 to 73.3) 0.28 24.3 (–2.3 to 50.9)
Teaching/Reg./Dist. Hospital –13.0 (–44.0 to 17.9) 0.36 –2.2 (–24.4 to 20.0)
Total (all facilities) –8.8 (–34.7, 17.1) 0.47 2.2 (–15.2 to 19.6)
Abbreviations: CI, conﬁdence interval; Diff., difference = (Proportion in 2010 – Proportion 20
pregnancy; Reg., Regional.
a Facilities that did not record the interventions or carry out HIV/syphilis tests were excludeleading to amuch larger decrease (16.4%) in estimates of uptake follow-
ing POCT rollout (Table 5).
Except for two health centers in the Northern region, all other facil-
ities offered HIV tests to pregnant women before or after syphilis POCT
rollout (Table 3); no HIV results were recorded in the registers of one
district hospital within the review period. Altogether, there was a mar-
ginal, non-signiﬁcant absolute increase of 2.2% in HIV testing in 2010
compared with the same period in 2009 (P= 0.8). Across regions, the
Northern region had a statistically signiﬁcant absolute increase of
24.2% in HIV testing (P= 0.04), while the other two regions recorded
non-signiﬁcant absolute decreases of less than 10% (Table 4). Adjusted
HIV testing uptake estimates were higher in 2009 and 2010, with an
increase in uptake of 5% (Table 5).
All health facilities administered IPTp and tetanus toxoid as part of
routine ANC in both years; three district hospitals (one in each region)
did not record both interventions in their ANC register during either
period (Table 3). Altogether, there were non-signiﬁcant absolute de-
creases of about 4% and 11% in IPTp and tetanus toxoid administration,
respectively (Table 4). Comparatively, adjusted uptake estimates for
IPTp and tetanus toxoid administration were higher in both years and
led to decreases in uptake of 8.8% and 33.3%, respectively (Table 5).
4. Discussion
4.1. Validation sub-study
Comparedwith theMRB as the gold standard, the completeness and
accuracy of ANC register data were reasonable for syphilis and HIV test-
ing, and constitute potential sources of information for monitoring ma-
ternal care. Although commonly used to assess the performance of
laboratory tests [18], sensitivity and speciﬁcity (including PPV and
NPV) analyses have also been used to validate and adjust for under-
recording in register records [9,10,14,17]. The validation measures in
the present study were characterized by: (1) variable levels of sensitiv-
ity, indicating variability of under-recording of test results and treat-
ments in the registers; (2) high levels of speciﬁcity, indicating that inermittent preventive treatment for malaria in pregnancy or tetanus toxoid administration,
re testing policy using antenatal care register records.a
IPTp Tetanus toxoid
P value % Diff. (95% CI) P value % Diff. (95% CI) P value
b0.001 25.0 (13.8− 36.2) b0.001 –3.3 (–6.6 to –0.1) 0.04
b0.001 6.7 (1.6− 11.8) 0.01 6.7 (–0.7 to 14.1) 0.08
.2) b0.001 2.1 (0.8− 3.5) 0.003 2.1 (0.8− 3.5) 0.003
b0.001 – – – –
0.04 –38.4 (–43.4 to –33.4) b0.001 –41.3 (–46.3 to –36.3) b0.001
0.79 –10.4 (–57.0 to 36.1) 0.53 –14.7 (–60.7 to 31.1) 0.38
b0.001 –9.2 (–21.4 to –2.9) 0.12 –4.2 (–16.8 to 8.4) 0.56
b0.001 5.8 (1.0− 10.6) 0.02 7.5 (2.7− 12.3) 0.002
0.005 10.2 (2.3− 18.1) 0.01 –3.4 (–8.2 to 1.4) 0.19
) b0.001 –8.1 (–10.7 to –5.5) b0.001 –22.1 (–26.1 to –18.2) b0.001
.2) b0.001 – – – –
0.57 –1.2 (–18.6 to 16.2) 0.84 –10.6 (–33.3 to 12.0) 0.23
– –61.3 (–71.4 to –51.3) b0.001 –67.2 (–76.7 to –57.7) b0.001
– –18.3 (–30.6 to –6.0) b0.001 –5.8 (–18.0 to 6.3) 0.34
b0.001 – – – –
– 21.2 (15.7− 26.6) b0.001 7.7 (1.7− 13.7) 0.01
b0.001 1.0 (–2.6 to 4.6) 0.62 –6.8 (–10.5 to –3.0) b0.001
0.04 –0.3 (–40.6 to 40.0) 0.98 –7.7 (–40.7 to 25.1) 0.51
0.06 –8.5 (–39.8 to 22.8) 0.52 –11.0 (–40.4 to 18.4) 0.38
0.82 –2.8 (–24.9 to 19.4) 0.76 –11.1 (–31.0 to 8.9) 0.21
0.79 –4.1 (–19.2 to 11.0) 0.56 –11.1 (–24.8 to 2.6) 0.10
09); Dist., District; Hosp., Hospital; IPTp, intermittent preventive treatment for malaria in
d from the analysis.
Table 5
Comparison of antenatal care register and adjusted estimates of uptake and differences in
uptake of antenatal syphilis andHIV testing, intermittent preventive treatment formalaria
in pregnancy, and tetanus toxoid administration in 2009 and 2010.
Intervention Sensitivity
(%)
ANC register estimates (%) Adjusted estimates (%)
2009 2010 Difference 2009 2010 Difference
Syphilis screening 53.8 26.9 18.1 –8.8 50.0 33.6 –16.4
HIV screening 43.1 27.6 29.8 2.2 64.0 69.1 5.1
IPTp 46.8 26.3 22.2 –4.1 56.2 47.4 –8.8
Tetanus toxoid 33.3 28.9 17.8 –11.1 86.8 53.5 –33.3
Abbreviations: ANC, antenatal care; IPTp, intermittent preventive treatment for malaria in
pregnancy.
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ments were recorded in the ANC register (i.e. false-positive recordings
were uncommon); (3) high PPVs, indicating that almost all the inter-
ventions recorded in the register were also found in the MRB; and
(4) higher levels of completeness and accuracy for recording AST results
compared with the other interventions.
The variable sensitivities and high speciﬁcities and PPVs found in the
study are consistent with results of other validation studies in the ante-
natal setting [10,14]. Being a relatively recent intervention, it is possible
that midwives/staff made conscious efforts to record AST results in the
ANC register, thus explaining the better sensitivity and accuracy
observed herein. Therefore, it is conceivable that syphilis POCT rollout
improved the quality of ANC register data; however, this is difﬁcult to
ascertain since we could not validate pre-rollout register data. Docu-
mentation of AST results in the ANC register also appears to have been
inﬂuenced by the seroprevalence of treponemal infections in each re-
gion. AST results were recorded in the ANC registers of all facilities in
the Central region, which had the highest treponemal seroprevalence,
while they were least recorded in antenatal registers in the Northern
region, where maternal syphilis was least prevalent.
These ﬁndings have some implications for the use of ANC register
data in monitoring uptake of antenatal interventions in Ghana. Such
data constitute an important resource for surveillance of maternal
health care, provided that sensitivity, speciﬁcity, PPV, or NPV are all
high. The quantiﬁcation of under recording in ANC registers allows for
adjustment of uptake estimates.4.2. Uptake of key antenatal interventions
Within the limitations of register data, there were signiﬁcant chang-
es in the uptake of the various interventions at the facility level, but gen-
erally non-signiﬁcant differences at the regional level. Nearly all women
booked for ANC before the third trimester. Most women who were
screened for syphilis did so before the third trimester, offering a good
opportunity to prevent congenital syphilis [1,3,19].
The rollout offered regions and facilities that were hitherto not rou-
tinely screening pregnant women for syphilis with an opportunity to
start testing. Expectedly, these facilities witnessed increases in screening
uptake due to their baseline value of zero. Quite detrimental to the pro-
gram, however, was the fact that all facilities that were previously
screening pregnant women for syphilis experienced a reduction in the
uptake of AST; an effect which was more marked in the larger facilities.
In a related (unpublished) study, most staff attributed the decrease
in screening uptake in 2010 largely to frequent stockouts and non-
replenishment of expired syphilis test kits. This suggests that the nation-
al program could have learnt from the good performance of facilities that
were already offering AST prior to the rollout. If some elements of the
existing system were not functioning properly and could be rectiﬁed,
then these should have been ﬁxed rather than implementing an entirely
new system [20,21]. For example, in a well-functioning system with
rapid plasma reagin testing, rapid syphilis POCTs could be introduced
as conﬁrmatory tests rather than replacing the entire testing system [20].The decrease in uptake of three interventions may suggest a general
problem of stockouts due to failures in the procurement chain or per-
haps a variation in motivational levels given that some facilities man-
aged to increase uptake. The overall marginal increase in HIV testing
may be attributed to it being a better resourced program [5] and to
test kits being supplied through a parallel system.
A much larger absolute decrease of about 16% was noted after
adjusting for under-recording of AST results in the register. It is possible
that the decrease could have been even larger (i.e. our pre-rollout up-
take may have been underestimated, as the sensitivity could have
been lower), since the rolloutmay have improved the quality of syphilis
data in the ANC register. Further, uptake of treatment for syphilis-
seropositive mothers was not documented owing to the lack of a syph-
ilis treatment column in the ANC register, which proved to be a useful
addition in Uganda [22].
The existence of separate registers for various interventions proba-
bly makes it easier to monitor each program’s progress. However, this
leads to fragmentation in documentation of client records and increases
staff workload [23]. It also fails to give a complete summary of antenatal
client evaluations andmanagement and defeats the purpose of integrat-
ed and focused ANC. Documentation of important client examinations
and treatments in the ANC registermakes it easier to assess andmonitor
obstetric care from a single source.
4.3. Limitations
A key limitation of our validation study is that theMRBmay not be a
perfect gold standard. The assumption that the interventions were not
given if they were not recorded in the MRB may not be entirely true
as staff may sometimes forget to appropriately record results or treat-
ments. However, the effects of this are expected to be quite minimal.
Other limitations include its restriction to “larger” healthcare facilities
owing to sample size requirements; thus, the effect of the rollout
could not be assessed in “smaller” healthcare facilities. Data were limit-
ed to four months in each year, which could have coincided with pe-
riods of stockouts in some facilities. Nevertheless, this provides an
indication of the availability of test kits and may suggest that facilities
would have experienced longer stockout periods had the review period
been extended. The different times of the rollout across the country and
the non-availability of registers for earlier years (for example, 2008) in
some facilities made it difﬁcult to prolong the review period. Finally,
the assumption that the sensitivities and speciﬁcities of recording the
interventions in the ANC register were the same before and after the
POCT rollout may not be entirely accurate, as the rollout could have
improved the quality of ANC register data.
5. Conclusions
Although the chosen antenatal interventionswere under-recorded in
most facilities, generally, the accuracy appeared high since most PPVs
were above 80%. However, given the variable levels of completeness
and accuracy for key indicators, routine monitoring of such prenatal in-
terventions using ANC register data may result in an underestimation
of their uptake. Meticulous recording by healthcare providers and regu-
lar audits could improve the quality and potential utility of ANC register
data. Whenever possible, ANC register and MRB data should be com-
bined to improve data quality.
Within the limitations of register data, the national rollout of syphilis
POCTs did not result in an overall increase in AST. However, signiﬁcant
increases were observed in healthcare facilities that were previously
not performing AST. A key lesson to be learnt from the rollout is “not
to replace,” but to learn from and improve on existing functioning sys-
tems. A column for recording syphilis treatment should be included in
the ANC register and efforts should be made to integrate all client re-
cords into the ANC register to provide a single comprehensive source
of client data.
S69E.T. Dassah et al. / International Journal of Gynecology and Obstetrics 130 (2015) S63–S69Acknowledgments
This research was supported by the Commonwealth Scholarships
Scheme, UK Department for International Development (DFID) Realising
Rights Research Programme Consortium, the University of London
Central Research Fund, and the Bill and Melinda Gates Foundation. We
are grateful to Professor DavidMabey, Dr HelenWeiss, and Dr Veronique
Filippi for their expert advice. We acknowledge the support of the
Medical Directors and staff of the selected health facilities.
Conﬂict of interest
The authors declare that they have no conﬂicts of interest.
References
[1] World Health Organization. The Global elimination of congenital syphilis: rationale
and strategy for action. Geneva: WHO; 2007.
[2] Gloyd S, Chai S, Mercer MA. Antenatal syphilis in sub-Saharan Africa: missed oppor-
tunities for mortality reduction. Health Policy Plan 2001;16:29–34.
[3] Mabey DC, Sollis KA, Kelly HA, Benzaken AS, Bitarakwate E, Changalucha J, et al.
Point-of-care tests to strengthen health systems and save newborn lives: the case
of syphilis. PLoS Med 2012;9:e1001233.
[4] Hawkes S, Matin N, Broutet N, Low N. Effectiveness of interventions to improve
screening for syphilis in pregnancy: a systematic review and meta-analysis. Lancet
Infect Dis 2011;11:684–91.
[5] Tulloch O, Mayaud P, Adu-Sarkodie Y, Opoku BK, Lithur NO, Sickle E, et al. Using re-
search to inﬂuence sexual and reproductive health practice and implementation in
Sub-Saharan Africa: a case-study analysis. Health Res Policy Syst 2011;9(Suppl. 1):
S10.
[6] Ghana Health Service. HIV sentinel survey report 2004. Accra: National AIDS/STI
Control Programme/Ghana Health Service; 2005.
[7] Ghana Health Service. HIV sentinel survey report 2008. Accra: National AIDS/STI
Control Programme/Ghana Health Service; 2009.
[8] World Health Organization. Joint United Nations Programme on HIV/AIDS, United
Nations Children’s Fund. Global HIV/AIDS response: epidemic update and health
sector progress towards universal access. Geneva:World Health Organization; 2011.[9] Taylor LK, Travis S, Pym M, Olive E, Henderson-Smart DJ. How useful are hospital
morbidity data for monitoring conditions occurring in the perinatal period? Aust
N Z J Obstet Gynaecol 2005;45:36–41.
[10] Lain SJ, Hadﬁeld RM, Raynes-Greenow CH, Ford JB, Mealing NM, Algert CS, et al.
Quality of data in perinatal population health databases: a systematic review. Med
Care 2012;50(4):e7-20.
[11] Ghana Health Service. 2010 HIV sentinel survey report. Accra: National AIDS/STI
Control Programme/Ghana Health Service; 2011.
[12] Ghana Statistical Service (GSS), Ghana Health Service (GHS), ICF Macro. Ghana
demographic and health survey 2008. Accra: GSS, GHS and ICF Macro; 2009.
[13] Ghana Health Service. National safe motherhood service protocols. Accra: Ghana
Health Service; 2008.
[14] Bell JC, Ford JB, Cameron CA, Roberts CL. The accuracy of population health data for
monitoring trends and outcomes amongwomenwith diabetes in pregnancy. Diabetes
Res Clin Pract 2008;81:105–9.
[15] Roberts CL, Cameron CA, Bell JC, Algert CS, Morris JM. Measuringmaternal morbidity
in routinely collected health data: development and validation of a maternal mor-
bidity outcome indicator. Med Care 2008;46:786–94.
[16] Looney SW, Hagan JL. Statistical methods for assessing biomarkers and for analyzing
biomarkers data. In: Rao CR,Miller JP, RaoDC, editors. Handbook of Statistics, volume
27: Epidemiology and medical statistics. Amsterdam: Elsevier; 2008. p. 109–47.
[17] Cameron CA, Roberts CL, Olive EC, Ford JB, Fischer WE. Trends in postpartum haem-
orrhage. Aust N Z J Public Health 2006;30:151–6.
[18] Mabey D, Peeling RW, Ballard R, Benzaken AS, Galbán E, Changalucha J, et al. Pro-
spective, multi-centre clinic-based evaluation of four rapid diagnostic tests for syph-
ilis. Sex Transm Infect 2006;82(Suppl. 5):v13–6.
[19] Watson-Jones D, Gumodoka B, Weiss H, Changalucha J, Todd J, Mugeye K, et al.
Syphilis in pregnancy in Tanzania. II. The effectiveness of antenatal syphilis screen-
ing and single-dose benzathine penicillin treatment for the prevention of adverse
pregnancy outcomes. J Infect Dis 2002;186:948–57.
[20] London School of Hygiene and Tropical Medicine. The rapid syphilis test toolkit: A
guide to planning, management and implementation. Management 3: Developing
syphilis testing and treatment algorithms using rapid tests. London: London School
of Hygiene and Tropical Medicine; 2011.
[21] World Health Organization. The use of rapid syphilis tests. Geneva: WHO; 2007.
[22] The Elizabeth Glaser Pediatric AIDS Foundation. Eliminating congenital syphilis in
Uganda. Mbara: The Elizabeth Glaser Pediatric AIDS Foundation; 2011.
[23] Gloyd S, Montoya P, Floriano F, Chadreque MC, Pfeiffer J, Gimbel-Sherr K. Scaling up
antenatal syphilis screening in Mozambique: transforming policy to action. Sex
Transm Dis 2007;34:S31–6.
